Rankings
▼
Calendar
ACAD Q4 2018 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$60M
+36.7% YoY
Gross Profit
$55M
92.6% margin
Operating Income
-$67M
-112.9% margin
Net Income
-$65M
-109.9% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
+2.2%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$40M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$540M
Total Liabilities
$61M
Stockholders' Equity
$479M
Cash & Equivalents
$135M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$60M
$44M
+36.7%
Gross Profit
$55M
$40M
+38.4%
Operating Income
-$67M
-$70M
+3.9%
Net Income
-$65M
-$69M
+4.9%
← FY 2018
All Quarters
Q1 2019 →